DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 18 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,000 | – | 521 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 275,000 | $1,103,000 | 0.40% |
| Manatuck Hill Partners, LLC | 273,100 | $1,095,000 | 0.38% |
| Stonepine Capital Management, LLC | 165,775 | $665,000 | 0.30% |
| Ikarian Capital, LLC | 311,041 | $1,247,000 | 0.09% |
| COOPERMAN LEON G | 200,000 | $802,000 | 0.04% |
| Jump Financial, LLC | 18,300 | $73,000 | 0.01% |
| Shay Capital LLC | 10,000 | $40,000 | 0.01% |
| Newbridge Financial Services Group, Inc. | 1,510 | $6,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 30,904 | $124,000 | 0.00% |
| Patriot Financial Group Insurance Agency, LLC | 1,300 | $5,000 | 0.00% |